Drugs / GRT3983Y
last change Jan 2011 re-read 3 minutes ago

GRT3983Y

Developed for
diabetic polyneuropathy
Investigated by
Grünenthal GmbH

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01056315 Nov 2009 → Jan 2011 diabetic polyneuropathy Grünenthal GmbH Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GRT3983Y “A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y” NCT01056315 ↗